The results of the trial into a new type of smart drug given to Acute Myeloid Leukaemia patients show that GO treatment could improve the effectiveness of chemotherapy without excessively increasing side effects, according to the study.
The study, published in the Journal of Clinical Oncology, said that this may provide a potential lifeline for older AML patients who are often too frail to tolerate more intensive chemotherapy regimes.
More top news
A doggy intelligence test may hold the key to a better understanding of human health problems like dementia, scientists say.
The Duchess says that children should be "supported through difficult times in their lives" at the start of Children's Mental Health Week.
The Met Police could soon be using birds of prey to help keep the skies above London clear of crime.